|
1
|
Yin SY, Lee JJ, Kim YM, Jin CM, Yang YJ,
Kang MH, Kai M and Lee MK: Effects of (1R,9S)-β-hydrastine on
L-DOPA-induced cytotoxicity in PC12 cells. Eur J Pharmacol.
488:71–77. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herath WH, Ferreira D and Khan IA:
Microbial transformation of the phthalideisoquinoline alkaloid,
(−)-beta-hydrastine. Nat Prod Res. 17:269–274. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weber HA, Zart MK, Hodges AE, Molloy HM,
O'Brien BM, Moody LA, Clark AP, Harris RK, Overstreet JD and Smith
CS: Chemical comparison of goldenseal (Hydrastis canadensis L.)
root powder from three commercial suppliers. J Agric Food Chem.
51:7352–7358. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cai XZ, Wang J, Li XD, Wang GL, Liu FN,
Cheng MS and Li F: Curcumin suppresses proliferation and invasion
in human gastric cancer cells by downregulation of PAK1 activity
and cyclin D1 expression. Cancer Biol Ther. 8:1360–1368. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thangapazham RL, Sharma A and Maheshwari
RK: Multiple molecular targets in cancer chemoprevention by
curcumin. AAPS J. 8:E443–E449. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saha SK, Sikdar S, Mukherjee A, Bhadra K,
Boujedaini N and Khuda-Bukhsh AR: Ethanolic extract of the
goldenseal, Hydrastis canadensis, has demonstrable chemopreventive
effects on HeLa cells in vitro: Drug-DNA interaction with calf
thymus DNA as target. Environ Toxicol Pharmacol. 36:202–214. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Das S, Das J, Samadder A, Bhattacharyya
SS, Das D and Khuda-Bukhsh AR: Biosynthesized silver nanoparticles
by ethanolic extracts of Phytolacca decandra, Gelsemium
sempervirens, Hydrastis canadensis and Thuja occidentalis induce
differential cytotoxicity through G2/M arrest in A375 cells.
Colloids Surf B Biointerfaces. 101:325–336. 2013. View Article : Google Scholar
|
|
8
|
Ke Y, Ye K, Grossniklaus HE, Archer DR,
Joshi HC and Kapp JA: Noscapine inhibits tumor growth with little
toxicity to normal tissues or inhibition of immune responses.
Cancer Immunol Immunother. 49:217–225. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ye K, Ke Y, Keshava N, Shanks J, Kapp JA,
Tekmal RR, Petros J and Joshi HC: Opium alkaloid noscapine is an
antitumor agent that arrests metaphase and induces apoptosis in
dividing cells. Proc Natl Acad Sci USA. 95:1601–1606. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kumar R, Gururaj AE and Barnes CJ:
p21-activated kinases in cancer. Nat Rev Cancer. 6:459–471. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wells CM and Jones GE: The emerging
importance of group II PAKs. Biochem J. 425:465–473. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kumar R and Vadlamudi RK: Emerging
functions of p21-activated kinases in human cancer cells. J Cell
Physiol. 193:133–144. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Callow MG, Clairvoyant F, Zhu S, Schryver
B, Whyte DB, Bischoff JR, Jallal B and Smeal T: Requirement for
PAK4 in the anchorage-independent growth of human cancer cell
lines. J Biol Chem. 277:550–558. 2002. View Article : Google Scholar
|
|
14
|
Kim JH, Kim HN, Lee KT, Lee JK, Choi SH,
Paik SW, Rhee JC and Lowe AW: Gene expression profiles in
gallbladder cancer: The close genetic similarity seen for early and
advanced gallbladder cancers may explain the poor prognosis. Tumour
Biol. 29:41–49. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Ke Q, Li Y, Liu F, Zhu G and Li F:
DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated
migration of human gastric cancer cell via LIMK1. Int J Biochem
Cell Biol. 42:70–79. 2010. View Article : Google Scholar
|
|
16
|
Liu Y, Xiao H, Tian Y, Nekrasova T, Hao X,
Lee HJ, Suh N, Yang CS and Minden A: The pak4 protein kinase plays
a key role in cell survival and tumorigenesis in athymic mice. Mol
Cancer Res. 6:1215–1224. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang C, Li Y, Zhang H, Liu F, Cheng Z,
Wang D, Wang G, Xu H, Zhao Y, Cao L, et al: Oncogenic PAK4
regulates Smad2/3 axis involving gastric tumorigenesis. Oncogene.
33:3473–3484. 2014. View Article : Google Scholar
|
|
18
|
Qu J, Cammarano MS, Shi Q, Ha KC, de
Lanerolle P and Minden A: Activated PAK4 regulates cell adhesion
and anchorage-independent growth. Mol Cell Biol. 21:3523–3533.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ahmed T, Shea K, Masters JR, Jones GE and
Wells CM: A PAK4-LIMK1 pathway drives prostate cancer cell
migration downstream of HGF. Cell Signal. 20:1320–1328. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo Q, Su N, Zhang J, Li X, Miao Z, Wang
G, Cheng M, Xu H, Cao L and Li F: PAK4 kinase-mediated SCG10
phosphorylation involved in gastric cancer metastasis. Oncogene.
33:3277–3287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deacon SW, Beeser A, Fukui JA, Rennefahrt
UE, Myers C, Chernoff J and Peterson JR: An isoform-selective,
small-molecule inhibitor targets the autoregulatory mechanism of
p21-activated kinase. Chem Biol. 15:322–331. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li X, Liu F and Li F: PAK as a therapeutic
target in gastric cancer. Expert Opin Ther Targets. 14:419–433.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Radu M, Semenova G, Kosoff R and Chernoff
J: PAK signalling during the development and progression of cancer.
Nat Rev Cancer. 14:13–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eswaran J, Soundararajan M and Knapp S:
Targeting group II PAKs in cancer and metastasis. Cancer Metastasis
Rev. 28:209–217. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Siu MK, Chan HY, Kong DS, Wong ES, Wong
OG, Ngan HY, Tam KF, Zhang H, Li Z, Chan QK, et al: p21-activated
kinase 4 regulates ovarian cancer cell proliferation, migration,
and invasion and contributes to poor prognosis in patients. Proc
Natl Acad Sci USA. 107:18622–18627. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fu X, Feng J, Zeng D, Ding Y, Yu C and
Yang B: PAK4 confers cisplatin resistance in gastric cancer cells
via PI3K/Akt- and MEK/Erk-dependent pathways. Biosci Rep. 34:59–67.
2014. View Article : Google Scholar
|
|
27
|
Bhat R, Xue Y, Berg S, Hellberg S, Ormö M,
Nilsson Y, Radesäter AC, Jerning E, Markgren PO, Borgegård T, et
al: Structural insights and biological effects of glycogen synthase
kinase 3-specific inhibitor AR-A014418. J Biol Chem.
278:45937–45945. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen C, Tang Y, Deng W, Huang C and Wu T:
Salidroside blocks the proliferation of pulmonary artery smooth
muscle cells induced by platelet-derived growth factor-BB. Mol Med
Rep. 10:917–922. 2014.PubMed/NCBI
|
|
29
|
Duiker EW, Mom CH, de Jong S, Willemse PH,
Gietema JA, van der Zee AG and de Vries EG: The clinical trail of
TRAIL. Eur J Cancer. 42:2233–2240. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gnesutta N, Qu J and Minden A: The
serine/threonine kinase PAK4 prevents caspase activation and
protects cells from apoptosis. J Biol Chem. 276:14414–14419.
2001.PubMed/NCBI
|
|
31
|
Zhang J, Wang J, Guo Q, Wang Y, Zhou Y,
Peng H, Cheng M, Zhao D and Li F: LCH-7749944, a novel and potent
p21-activated kinase 4 inhibitor, suppresses proliferation and
invasion in human gastric cancer cells. Cancer Lett. 317:24–32.
2012. View Article : Google Scholar
|
|
32
|
Park MH, Lee HS, Lee CS, You ST, Kim DJ,
Park BH, Kang MJ, Heo WD, Shin EY, Schwartz MA, et al:
p21-activated kinase 4 promotes prostate cancer progression through
CREB. Oncogene. 32:2475–2482. 2013. View Article : Google Scholar
|
|
33
|
Ryu BJ, Lee H, Kim SH, Heo JN, Choi SW,
Yeon JT, Lee J, Lee J, Cho JY, Kim SH, et al: PF-3758309,
p21-activated kinase 4 inhibitor, suppresses migration and invasion
of A549 human lung cancer cells via regulation of CREB, NF-κB, and
β-catenin signalings. Mol Cell Biochem. 389:69–77. 2014. View Article : Google Scholar
|
|
34
|
Tamaoki T, Nomoto H, Takahashi I, Kato Y,
Morimoto M and Tomita F: Staurosporine, a potent inhibitor of
phospholipid/Ca++dependent protein kinase. Biochem Biophys Res
Commun. 135:397–402. 1986. View Article : Google Scholar : PubMed/NCBI
|
